649 related articles for article (PubMed ID: 15778064)
41. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
[TBL] [Abstract][Full Text] [Related]
42. Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells.
Yadav S; van Vlerken LE; Little SR; Amiji MM
Cancer Chemother Pharmacol; 2009 Mar; 63(4):711-22. PubMed ID: 18618115
[TBL] [Abstract][Full Text] [Related]
43. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
[TBL] [Abstract][Full Text] [Related]
44. A systematic SPR study of human plasma protein adsorption behavior on the controlled surface packing of self-assembled poly(ethylene oxide) triblock copolymer surfaces.
Chang Y; Chu WL; Chen WY; Zheng J; Liu L; Ruaan RC; Higuchi A
J Biomed Mater Res A; 2010 Apr; 93(1):400-8. PubMed ID: 19569222
[TBL] [Abstract][Full Text] [Related]
45. Biodegradable nanoparticles of amphiphilic triblock copolymers based on poly(3-hydroxybutyrate) and poly(ethylene glycol) as drug carriers.
Chen C; Yu CH; Cheng YC; Yu PH; Cheung MK
Biomaterials; 2006 Sep; 27(27):4804-14. PubMed ID: 16740306
[TBL] [Abstract][Full Text] [Related]
46. Mannosylated poly(ethylene oxide)-b-poly(epsilon-caprolactone) diblock copolymers: synthesis, characterization, and interaction with a bacterial lectin.
Rieger J; Stoffelbach F; Cui D; Imberty A; Lameignere E; Putaux JL; Jérôme R; Jérôme C; Auzély-Velty R
Biomacromolecules; 2007 Sep; 8(9):2717-25. PubMed ID: 17705426
[TBL] [Abstract][Full Text] [Related]
47. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
Falamarzian A; Lavasanifar A
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
[TBL] [Abstract][Full Text] [Related]
48. Mechanism of gold metal ion reduction, nanoparticle growth and size control in aqueous amphiphilic block copolymer solutions at ambient conditions.
Sakai T; Alexandridis P
J Phys Chem B; 2005 Apr; 109(16):7766-77. PubMed ID: 16851902
[TBL] [Abstract][Full Text] [Related]
49. Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers.
Zhao J; Liu CS; Yuan Y; Tao XY; Shan XQ; Sheng Y; Wu F
Biomaterials; 2007 Mar; 28(7):1414-22. PubMed ID: 17126898
[TBL] [Abstract][Full Text] [Related]
50. Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery.
Park EK; Kim SY; Lee SB; Lee YM
J Control Release; 2005 Dec; 109(1-3):158-68. PubMed ID: 16263189
[TBL] [Abstract][Full Text] [Related]
51. Traceable PEO-poly(ester) micelles for breast cancer targeting: The effect of core structure and targeting peptide on micellar tumor accumulation.
Garg SM; Paiva IM; Vakili MR; Soudy R; Agopsowicz K; Soleimani AH; Hitt M; Kaur K; Lavasanifar A
Biomaterials; 2017 Nov; 144():17-29. PubMed ID: 28818703
[TBL] [Abstract][Full Text] [Related]
52. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size.
Fang C; Shi B; Pei YY; Hong MH; Wu J; Chen HZ
Eur J Pharm Sci; 2006 Jan; 27(1):27-36. PubMed ID: 16150582
[TBL] [Abstract][Full Text] [Related]
53. XPS and wettability characterization of modified poly(lactic acid) and poly(lactic/glycolic acid) films.
Kiss E; Bertóti I; Vargha-Butler EI
J Colloid Interface Sci; 2002 Jan; 245(1):91-8. PubMed ID: 16290340
[TBL] [Abstract][Full Text] [Related]
54. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
[TBL] [Abstract][Full Text] [Related]
55. The effect of hydrophilic chain length and iRGD on drug delivery from poly(ε-caprolactone)-poly(N-vinylpyrrolidone) nanoparticles.
Zhu Z; Xie C; Liu Q; Zhen X; Zheng X; Wu W; Li R; Ding Y; Jiang X; Liu B
Biomaterials; 2011 Dec; 32(35):9525-35. PubMed ID: 21903260
[TBL] [Abstract][Full Text] [Related]
56. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly (ethylene glycol) and polycaprolactone.
Zhang Y; Zhuo RX
Biomaterials; 2005 Nov; 26(33):6736-42. PubMed ID: 15935469
[TBL] [Abstract][Full Text] [Related]
58. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.
Duan Y; Xu J; Lin Y; Yu H; Gong T; Li Y; Zhang Z
J Biomed Mater Res A; 2008 Nov; 87(2):515-23. PubMed ID: 18186066
[TBL] [Abstract][Full Text] [Related]
59. Preparation of mannan modified anionic PCL-PEG-PCL nanoparticles at one-step for bFGF antigen delivery to improve humoral immunity.
Gou M; Dai M; Li X; Yang L; Huang M; Wang Y; Kan B; Lu Y; Wei Y; Qian Z
Colloids Surf B Biointerfaces; 2008 Jun; 64(1):135-9. PubMed ID: 18249528
[TBL] [Abstract][Full Text] [Related]
60. Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs.
Park EK; Lee SB; Lee YM
Biomaterials; 2005 Mar; 26(9):1053-61. PubMed ID: 15369694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
